Imaging characteristic of dual-phase 18F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment

被引:42
|
作者
Lin, Kun-Ju [1 ,2 ,3 ,4 ]
Hsiao, Ing-Tsung [1 ,2 ,3 ,4 ]
Hsu, Jung-Lung [5 ,6 ]
Huang, Chin-Chang [7 ]
Huang, Kuo-Lun [7 ]
Hsieh, Chia-Ju [1 ,2 ,3 ,4 ]
Wey, Shiaw-Pyng [1 ,2 ,3 ,4 ]
Yen, Tzu-Chen [1 ,2 ,3 ,4 ]
机构
[1] Linkou Chang Gung Mem Hosp & Univ, Dept Nucl Med, 5 Fu Hsing St, Taoyuan, Taiwan
[2] Linkou Chang Gung Mem Hosp & Univ, Mol Imaging Ctr, 5 Fu Hsing St, Taoyuan, Taiwan
[3] Chang Gung Univ, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan
[4] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan
[5] Linkou Chang Gung Mem Hosp, Sect Dementia & Cognit Impairment, Dept Neurol, Taoyuan, Taiwan
[6] Taipei Med Univ, Grad Inst Humanities Med, Taipei, Taiwan
[7] Linkou Chang Gung Mem Hosp & Univ, Dept Neurol, Taoyuan, Taiwan
关键词
Dual-phase scan; Perfusion deficits; Amyloid; F-18-Florbetapir (AV-45/Amyvid); Alzheimer's disease; Dementia; Mild cognitive impairment; CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; PITTSBURGH COMPOUND-B; F-18-FDG PET; HUMAN BRAIN; FDG-PET; DEMENTIA; DIAGNOSIS; PREVALENCE; METABOLISM;
D O I
10.1007/s00259-016-3359-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Pyrpose We investigated dual-phase F-18-florbetapir (AV-45/Amyvid) PET imaging for the concomitant detection of brain perfusion deficits and beta-amyloid deposition in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (MCI), and in cognitively healthy controls (HCs). Methods A total of 82 subjects (24 AD patients, 44 MCI patients and 14 HCs) underwent both dual-phase F-18-AV-45 PET and MRI imaging. Dual-phase dynamic PET imaging consisted of (1) five 1-min scans obtained 1-6 min after tracer injection (perfusion F-18-AV-45 imaging, pAV-45), and (2) ten 1-min scans obtained 50-60 min after tracer injection (amyloid F-18-AV-45 imaging). Amyloid-negative MCI/AD patients were excluded. Volume of interest analysis and statistical parametric mapping of pAV-45 and F-18-AV-45 images were performed to investigate the perfusion deficits and the beta-amyloid burden in the three study groups. The associations between Mini-Mental State Examination (MMSE) scores and global perfusion deficits and amyloid deposition were investigated with linear and segmental linear correlation analyses. Results HCs generally had normal pAV-45 findings, whereas perfusion deficits were evident in the hippocampus, and temporal, parietal and middle frontal cortices in both MCI and AD patients. The motor-sensory cortex was relatively preserved. MMSE scores in the entire study cohort were significantly associated with the degree of perfusion impairment as assessed by pAV-45 imaging (r = 0.5156, P < 0.0001). F-18-AV-45 uptake was significantly higher in AD patients than in the two other study groups. However, the correlation between MMSE scores and F-18-AV-45 uptake in MCI patients was more of a binary phenomenon and began in MCI patients with MMSE score 23.14 when F-18-AV-45 uptake was higher and MMSE score lower than in patients with early MCI. Amyloid deposition started in the precuneus and the frontal and temporal regions in early MCI, ultimately reaching the maximum burden in advanced MCI. Conclusion Our results indicate that brain perfusion deficits and beta-amyloid deposition in AD follow different trajectories that can be successfully traced using dual-phase F-18-AV-45 PET imaging.
引用
收藏
页码:1304 / 1314
页数:11
相关论文
共 15 条
  • [1] Imaging characteristic of dual-phase 18F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer’s disease and mild cognitive impairment
    Kun-Ju Lin
    Ing-Tsung Hsiao
    Jung-Lung Hsu
    Chin-Chang Huang
    Kuo-Lun Huang
    Chia-Ju Hsieh
    Shiaw-Pyng Wey
    Tzu-Chen Yen
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1304 - 1314
  • [2] Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study
    Wu, Kuan-Yi
    Liu, Chia-Yih
    Chen, Cheng-Sheng
    Chen, Chia-Hsiang
    Hsiao, Ing-Tsung
    Hsieh, Chia-Ju
    Lee, Chin-Pang
    Yen, Tzu-Chen
    Lin, Kun-Ju
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (06) : 1067 - 1076
  • [3] Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study
    Kuan-Yi Wu
    Chia-Yih Liu
    Cheng-Sheng Chen
    Chia-Hsiang Chen
    Ing-Tsung Hsiao
    Chia-Ju Hsieh
    Chin-Pang Lee
    Tzu-Chen Yen
    Kun-Ju Lin
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1067 - 1076
  • [4] Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study
    Matsuda, Hiroshi
    Okita, Kyoji
    Motoi, Yumiko
    Mizuno, Toshiki
    Ikeda, Manabu
    Sanjo, Nobuo
    Murakami, Koji
    Kambe, Taiki
    Takayama, Toshiki
    Yamada, Kei
    Suehiro, Takashi
    Matsunaga, Keiko
    Yokota, Takanori
    Tateishi, Ukihide
    Shigemoto, Yoko
    Kimura, Yukio
    Chiba, Emiko
    Kawashima, Takahiro
    Tomo, Yui
    Tachimori, Hisateru
    Kimura, Yuichi
    Sato, Noriko
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (12) : 1039 - 1049
  • [5] Regional Amyloid Deposition in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Evaluated by [18F]AV-45 Positron Emission Tomography in Chinese Population
    Huang, Kuo-Lun
    Lin, Kun-Ju
    Hsiao, Ing-Tsung
    Kuo, Hung-Chou
    Hsu, Wen-Chuin
    Chuang, Wen-Li
    Kung, Mei-Ping
    Wey, Shiaw-Pyng
    Hsieh, Chia-Ju
    Wai, Yau-Yau
    Yen, Tzu-Chen
    Huang, Chin-Chang
    PLOS ONE, 2013, 8 (03):
  • [6] Dual-phase 18F-florbetaben PET provides cerebral perfusion proxy along with beta-amyloid burden in Alzheimer's disease
    Yoon, Hai-Jeon
    Kim, Bom Sahn
    Jeong, Jee Hyang
    Kim, Geon Ha
    Park, Hee Kyung
    Chun, Min Young
    Ha, Seunggyun
    NEUROIMAGE-CLINICAL, 2021, 31
  • [7] Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study
    Hiroshi Matsuda
    Kyoji Okita
    Yumiko Motoi
    Toshiki Mizuno
    Manabu Ikeda
    Nobuo Sanjo
    Koji Murakami
    Taiki Kambe
    Toshiki Takayama
    Kei Yamada
    Takashi Suehiro
    Keiko Matsunaga
    Takanori Yokota
    Ukihide Tateishi
    Yoko Shigemoto
    Yukio Kimura
    Emiko Chiba
    Takahiro Kawashima
    Yui Tomo
    Hisateru Tachimori
    Yuichi Kimura
    Noriko Sato
    Annals of Nuclear Medicine, 2022, 36 : 1039 - 1049
  • [8] Alterations in Gut Microbiota and Their Correlation with Brain Beta-Amyloid Burden Measured by 18F-Florbetaben PET in Mild Cognitive Impairment Due to Alzheimer's Disease
    Kim, Geon Ha
    Kim, Bori R.
    Yoon, Hai-Jeon
    Jeong, Jee Hyang
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [9] In vivo PET imaging of beta-amyloid deposition in mouse models of Alzheimer's disease with a high specific activity PET imaging agent [18F]flutemetamol
    Snellman, Anniina
    Rokka, Johanna
    Lopez-Picon, Francisco R.
    Eskola, Olli
    Salmona, Mario
    Forloni, Gianluigi
    Scheinin, Mika
    Solin, Olof
    Rinne, Juha O.
    Haaparanta-Solin, Merja
    EJNMMI RESEARCH, 2014, 4 : 1 - 11
  • [10] 18F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer's Disease Patients
    Chang, Yan
    Li, Can
    Yang, Hui
    Wu, Yue
    Xu, Baixuan
    Zhang, Jinming
    Wang, Ruimin
    FRONTIERS IN NEUROSCIENCE, 2020, 14